Small Lymphocytic Lymphoma — Trials

Small Lymphocytic Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

479 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 129
Recruiting: 67
Ph III recruiting: 9
Growth YoY: −23.8%
Industry share: 37%
Top sponsor: National Cancer Institute (NCI)
Termination share: 41.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (108)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04578613	ICP-022 Versus Chlorambucil Combined With Rituximab in the Treatment of Untreated CLL/SLL	unknown	Phase 3	218	Beijing InnoCare Pharma Tech Co., Ltd.INDUSTRY	1	Jun 5, 2023	clinicaltrials
NCT02991638	Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers	unknown	Phase 3	62	The University of Hong KongOTHER	1	Apr 12, 2018